CGS 21680 HCl 5mg | Purity Not Available
Selleck Chemicals
CGS 21680 HCl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.
More Information Supplier PageCGS 21680 HCl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.
More Information Supplier PageCGS 21680 HCl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.
More Information Supplier PageCGS 21680 HCl is an adenosine A2 receptor agonist with IC50 of 22 nM, exhibits 140-fold over A1 receptor.
More Information Supplier PageLY2886721 is a BACE inhibitor used for the treatment of Alzheimer’s Disease. Phase 1/2.
More Information Supplier PageLY2886721 is a BACE inhibitor used for the treatment of Alzheimer’s Disease. Phase 1/2.
More Information Supplier PageAZD8330 (ARRY704) is a novel, selective, non-ATP competitive MEK 1/2 inhibitor with IC50 of 7 nM. Phase 1.
More Information Supplier PageNeratinib is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM in cell-free assays; weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.
More Information Supplier PageGabapentin is a GABA analogue, used to treat seizures and neuropathic pain.
More Information Supplier PageRoflumilast is a selective inhibitor of PDE4 with IC50 of 0.2-4.3 nM in a cell-free assay.
More Information Supplier Page